These 10 medications are likely targets for Medicare price negotiations this fall
Publishing timestamp: 2023-08-11 11:17:16
Summary
Medicare is set to announce 10 drugs that will be subject to price negotiations with the pharmaceutical industry. Several pharmaceutical companies have already revealed that they expect some of their blockbuster medications to be targeted. The negotiations are part of the Biden administration's efforts to reduce drug costs. The list price of many drugs has significantly increased over the years, exceeding the rate of inflation. However, the pharmaceutical industry has filed lawsuits to block the negotiations, arguing that it is unconstitutional. The negotiations are scheduled to take place in 2024, with reduced prices going into effect in 2026.
Sentiment: MIXED
Tickers: GSK, MRK, PFE, 4503.T-JP, JNJ, AZN-GB, ABBV, AMGN, BMY, GSK-GB,
Keywords: astrazeneca plc, biotech and pharmaceuticals, merck & co inc, u.s. economy, amgen inc, breaking news: business, astellas pharma inc, business, johnson & johnson, bristol-myers squibb co, health care industry, biotechnology, business news, gsk plc, pfizer inc, abbvie inc, politics,